In contrast, in SLE patients (both males and females) PBMCs treated with E2 at a physiological dose (60 pg/ml) was associated with significantly reduced FoxP3 mRNA expression (Figures 6A,B). The gene discussed is FOXP3; the disease is systemic lupus erythematosus.